The blood test measures p-tau217, which indicates the presence of amyloid and tau proteins - hallmarks of Alzheimer’s disease - in the brain.
“It’s a really exciting time for dementia research,” said Professor Ramin Nilforooshan, a consultant psychiatrist at Surrey and Borders Partnership NHS (SABP). Although dementia is often spoken about ...
Hampshire Chronicle on MSN
Groundbreaking dementia trial underway at Hampshire health trust
The blood test measures p-tau217, which indicates the presence of amyloid and tau proteins - hallmarks of Alzheimer’s disease - in the brain.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results